226 related articles for article (PubMed ID: 26882490)
21. Avanafil for the treatment of erectile dysfunction. An updated review.
Egui-Rojo MA; Moncada-Iribarren I; Carballido-Rodríguez J; Martínez-Salamanca JI
Arch Esp Urol; 2014 Dec; 67(10):839-47. PubMed ID: 25582903
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of mirodenafil in men taking antihypertensive medications.
Paick JS; Kim JJ; Kim SC; Moon KH; Min KS; Park K; Suh JK; Yang DY
J Sex Med; 2010 Sep; 7(9):3143-52. PubMed ID: 20649936
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of phosphodieterase-5 inhibitors for the treatment of erectile dysfunction secondary to spinal cord injury.
Wyndaele JJ
Spinal Cord; 2016 Jul; 54(7):493. PubMed ID: 27345458
[No Abstract] [Full Text] [Related]
24. Treating erectile dysfunction and central neurological diseases with oral phosphodiesterase type 5 inhibitors. Review of the literature.
Lombardi G; Nelli F; Celso M; Mencarini M; Del Popolo G
J Sex Med; 2012 Apr; 9(4):970-85. PubMed ID: 22304626
[TBL] [Abstract][Full Text] [Related]
25. Ten years of phosphodiesterase type 5 inhibitors in spinal cord injured patients.
Lombardi G; Macchiarella A; Cecconi F; Del Popolo G
J Sex Med; 2009 May; 6(5):1248-58. PubMed ID: 19210710
[TBL] [Abstract][Full Text] [Related]
26. Safety and efficacy of vardenafil, a selective phosphodiesterase 5 inhibitor, in patients with erectile dysfunction and arterial hypertension treated with multiple antihypertensives.
van Ahlen H; Wahle K; Kupper W; Yassin A; Reblin T; Neureither M
J Sex Med; 2005 Nov; 2(6):856-64. PubMed ID: 16422810
[TBL] [Abstract][Full Text] [Related]
27. A randomized, double-blind, placebo-controlled evaluation of the safety and efficacy of avanafil in subjects with erectile dysfunction.
Goldstein I; McCullough AR; Jones LA; Hellstrom WJ; Bowden CH; Didonato K; Trask B; Day WW
J Sex Med; 2012 Apr; 9(4):1122-33. PubMed ID: 22248153
[TBL] [Abstract][Full Text] [Related]
28. Effect of Antioxidants Supplementation on Erectile Dysfunction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Su L; Yang ZT; Qu H; Luo CL; Yuan GX; Wu J; Jiao YZ
Sex Med Rev; 2022 Oct; 10(4):754-763. PubMed ID: 37051969
[TBL] [Abstract][Full Text] [Related]
29. A therapeutic confirmatory study to assess the safety and efficacy of Zydena (udenafil) for the treatment of erectile dysfunction in male patients with diabetes mellitus.
Moon du G; Yang DY; Lee CH; Ahn TY; Min KS; Park K; Park JK; Kim JJ
J Sex Med; 2011 Jul; 8(7):2048-61. PubMed ID: 21554549
[TBL] [Abstract][Full Text] [Related]
30. A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with α-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia.
Gacci M; Corona G; Salvi M; Vignozzi L; McVary KT; Kaplan SA; Roehrborn CG; Serni S; Mirone V; Carini M; Maggi M
Eur Urol; 2012 May; 61(5):994-1003. PubMed ID: 22405510
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of avanafil for treating erectile dysfunction: results of a multicentre, randomized, double-blind, placebo-controlled trial.
Zhao C; Kim SW; Yang DY; Kim JJ; Park NC; Lee SW; Paick JS; Ahn TY; Moon KH; Chung WS; Min KS; Suh JK; Hyun JS; Park K; Park JK
BJU Int; 2012 Dec; 110(11):1801-6. PubMed ID: 22448738
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of mirodenafil, a new oral phosphodiesterase type 5 inhibitor, for treatment of erectile dysfunction.
Paick JS; Ahn TY; Choi HK; Chung WS; Kim JJ; Kim SC; Kim SW; Lee SW; Min KS; Moon KH; Park JK; Park K; Park NC; Suh JK; Yang DY; Jung HG
J Sex Med; 2008 Nov; 5(11):2672-80. PubMed ID: 18638004
[TBL] [Abstract][Full Text] [Related]
33. Tadalafil 5 mg Once Daily Improves Lower Urinary Tract Symptoms and Erectile Dysfunction: A Systematic Review and Meta-analysis.
Wang Y; Bao Y; Liu J; Duan L; Cui Y
Low Urin Tract Symptoms; 2018 Jan; 10(1):84-92. PubMed ID: 29341503
[TBL] [Abstract][Full Text] [Related]
34. Effect of Antioxidants Supplementation on Erectile Dysfunction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Su L; Yang ZT; Qu H; Luo CL; Yuan GX; Wu J; Jiao YZ
Sex Med Rev; 2022 Oct; 10(4):754-763. PubMed ID: 35246405
[TBL] [Abstract][Full Text] [Related]
35. Combination of psychological intervention and phosphodiesterase-5 inhibitors for erectile dysfunction: a narrative review and meta-analysis.
Schmidt HM; Munder T; Gerger H; Frühauf S; Barth J
J Sex Med; 2014 Jun; 11(6):1376-91. PubMed ID: 24641632
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction in elderly men and those with underlying conditions: an integrated analysis of two pivotal trials.
Sperling H; Gittelman M; Norenberg C; Ulbrich E; Ewald S
J Sex Med; 2011 Jan; 8(1):261-71. PubMed ID: 20807322
[TBL] [Abstract][Full Text] [Related]
37. The efficacy and safety of vardenafil in East Asian men with erectile dysfunction.
Chen KK; Paick JS; Ishii N; On Behalf Of The Vardenafil Study Group
J Sex Med; 2007 May; 4(3):753-761. PubMed ID: 17498108
[TBL] [Abstract][Full Text] [Related]
38. [Treatment of male erectile dysfunction following spinal cord injuries using PDE5 inhibitors].
Srámková T; Sutorý M
Rozhl Chir; 2008 May; 87(5):250-4. PubMed ID: 18595542
[TBL] [Abstract][Full Text] [Related]
39. Phosphodiesterase type 5 inhibitor treatment for erectile dysfunction in patients with end-stage renal disease receiving dialysis or after renal transplantation.
Lasaponara F; Sedigh O; Pasquale G; Bosio A; Rolle L; Ceruti C; Timpano M; Negro CL; Paradiso M; Abbona A; Segoloni GP; Fontana D
J Sex Med; 2013 Nov; 10(11):2798-814. PubMed ID: 23346948
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of phosphodiesterase type 5 inhibitors in patients with erectile dysfunction after nerve-sparing radical prostatectomy: a systematic review and meta-analysis.
Goh HJ; Sung JM; Lee KH; Jo JK; Kim KN
Transl Androl Urol; 2022 Feb; 11(2):124-138. PubMed ID: 35280664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
